Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th
Newsquawk Staff ·
Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th.
What it means
Chinese AI labs releasing open-weight frontier-class models on short cycles has become a recurring pattern, and the market read-through has been consistent: the pressure lands on the compute-demand and pricing-power assumptions behind the US model providers and their cloud backers, not on the releasing lab itself. Claims of benchmark superiority, particularly on agentic and long-horizon coding tasks, are the current differentiator because that is where commercial pricing power sits; prior episodes of comparable open releases have tended to compress the perceived moat of closed-source leaders and to revive the debate over whether model capability is commoditising faster than capex can monetise. The open-weights pledge is the operative element here, since open availability has historically accelerated enterprise adoption of cheaper alternatives and weighed on API pricing across the peer set. The self-reported benchmark claims warrant the usual discount until independently replicated, a distinction that has mattered in past release cycles. The follow-ons are the US labs' response timing, any pricing moves, and how the AI-heavy US equity complex treats another datapoint in the commoditisation narrative. As a product announcement rather than earnings or policy, the signal is directional for sentiment, not mechanical.
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 2027
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce
- Nvidia (NVDA) launches Minerva platform for end-to-end AI factory observability
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile
Related headlines
- OpenAI reveals plans for an in-house exabyte-scale storage system1 hour ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter1 hour ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 1 hour ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability2 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine2 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)2 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed2 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders4 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer4 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation4 hours ago
- American Express (AXP) to cut 5% of jobs5 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM5 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years5 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months6 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)6 hours ago